Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9517598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover

  2004cited by this paper
• Altered trabecular architecture induced by Corticosteroids: A Bone Histomorphometric Study

  1996cited by this paper
• Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.

  1996cited by this paper
• Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.

  1996cited by this paper
• Comparison of rates of bone loss from the spine measured using two manufacturers' densitometers

  1995cited by this paper
• Fluticasone propionate--an update on preclinical and clinical experience.

  1995cited by this paper
• A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthma

  1994cited by this paper
• Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate.

  1994cited by this paper
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.

  1994cited by this paper
• Universal standardization for dual X‐ray absorptiometry: Patient and phantom cross‐calibration results

  1994cited by this paper
• Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids.

  1994cited by this paper
• Glucocorticoids and osteoporosis.

  1994cited by this paper
• Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism.

  1994cited by this paper
• A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.

  1993cited by this paper
• Quality assurance for bone densitometry research studies: Concept and impact

  1993cited by this paper
• Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.

  1993cited by this paper
• Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler.

  1993cited by this paper
• Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen

  1992cited by this paper
• The Living with Asthma Questionnaire.

  1991cited by this paper
• Locomotor side-effects of corticosteroids.

  1991cited by this paper
• Corticosteroid effects on proximal femur bone loss

  1990cited by this paper
• The human pharmacology of fluticasone propionate.

  1990cited by this paper
• Steroid-induced fractures and bone loss in patients with asthma.

  1983cited by this paper
• The two-period cross-over clinical trial.

  1979cited by this paper

• Is asthma a protective factor for dengue fever? In vitro experiment and nationwide population-based cohort analysis.

  2019cites this paper
• Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.

  2018cites this paper
• Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma

  2017cites this paper
• Spirometry utilisation among Danish adults initiating medication targeting obstructive lung disease.

  2015cites this paper
• [A new fixed dose combination of fluticasone and formoterol in a pressurised metered-dose inhaler for the treatment of asthma].

  2014cites this paper
• Suppressive effects of long-term treatment with inhaled steroids on hypothalamic-pituitary-adrenal axis in asthma

  2014cites this paper
• Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.

  2013cites this paper
• The effect of inhaled corticosteroids on hypothalamic-pituitary-adrenal axis

  2012cites this paper
• The Influence of Inhaled Fluticasone on Bone Metabolism and Calciuria in Asthmatic Children

  2011cites this paper
• Turkish Thoracic Society asthma management and prevention guideline: key points.

  2011cites this paper
• Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs

  2011cites this paper
• Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.

  2010cites this paper
• Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.

  2010cites this paper
• Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

  2010cites this paper
• Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol

  2010cites this paper
• Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.

  2009cites this paper
• TÜRK TORAKS DERNEĞİ ASTIM TANI VE TEDAVİ REHBERİ

  2009cites this paper
• Global strategy for asthma management and prevention: GINA executive summary

  2008cites this paper
• [Fluticasone propionate in children and infants with asthma].

  2007cites this paper
• Evidence-Based Selection of Inhaled Corticosteroid for Treatment of Chronic Asthma

  2007cites this paper
• Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.

  2007cites this paper
• Cost-effectiveness of inhaled steroids in asthma: impact of effect on bone mineral density.

  2006cites this paper
• Factors associated with poor asthma control in children aged five to 13 years.

  2006cites this paper
• What Does Potency Actually Mean for Inhaled Corticosteroids?

  2005cites this paper
• Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

  2005cites this paper
• Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.

  2005cites this paper
• Pharmacokinetic and Pharmacodynamic Properties of Inhaled Beclometasone Dipropionate Delivered Via Hydrofluoroalkane-Containing Devices

  2005cites this paper
• Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children.

  2005cites this paper
• Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.

  2004cites this paper
• Loss of bone density with inhaled triamcinolone in Lung Health Study II.

  2004cites this paper
• Biochemical markers of bone metabolism and calciuria with inhaled budesonide therapy

  2004cites this paper
• Efficacy of fluticasone propionate compared with beclomethasone dipropionate in bronchial asthma: improvement in compliance and symptoms by fluticasone.

  2003cites this paper
• Glucocorticoid-induced osteoporosis: pathophysiological data and recent treatments.

  2003cites this paper
• Adrenal Function as Assessed by Low-Dose Adrenocorticotropin Hormone Test Before and After Switching from Inhaled Beclomethasone Dipropionate to Inhaled Fluticasone Propionate

  2003cites this paper
• Comparison of the Systemic Effects of Fluticasone Propionate and Triamcinolone Acetonide Administered in Equipotent Doses in Children with Asthma

  2003cites this paper
• Viruses in asthma

  2002cites this paper
• Effects of fluticasone propionate on bone mineral density in patients with persistent bronchial asthma.

  2002cites this paper
• Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease.

  2002cites this paper
• Changing approaches to asthma management in Australia: effects on asthma morbidity.

  2001cites this paper
• Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.

  2001cites this paper
• Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma.

  2001cites this paper
• A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.

  2001cites this paper
• Improved safety with equivalent asthma control in adults with chronic severe asthma on high‐dose fluticasone propionate

  2001cites this paper
• Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up.

  2001cites this paper
• Safety of inhaled corticosteroids in children with asthma

  2001cites this paper
• Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.

  2000cites this paper
• Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects

  2000cites this paper
• Applicability of Hyland's Living with Asthma Questionnaire for Japanese asthmatic patients.

  2000cites this paper
• Effect of an inhaled glucocorticoid, flunisolide, on bone mineral density: a 2-year prospective, controlled trial.

  2000cites this paper
• Glucocorticoid-induced osteoporosis.

  2000cites this paper
• Bone mineral density in women with asthma on long-term inhaled corticosteroid therapy.

  2000cites this paper
• Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids.

  2000cites this paper
• The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI).

  2000cites this paper
• A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma.

  1999cites this paper
• Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

  1999cites this paper
• Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.

  1999cites this paper
• Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.

  1999cites this paper
• Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.

  1999cites this paper
• Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: A literature review

  1999cites this paper
• The therapeutic potential of PDE4 inhibitors.

  1999cites this paper
• Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease (COPD).

  1999cites this paper
• One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density

  1999cites this paper
• Establishing a therapeutic index for the inhaled corticosteroids: part II. Comparisons of systemic activity and safety among different inhaled corticosteroids.

  1998cites this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cites this paper
• Corticosteroid Therapy in Asthma

  1961cites this paper